Lymphoma Research Foundation
Based in NY
🤖
AI Overview
With $0 in lobbying spend across 32 quarterly filings, Lymphoma Research Foundation is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
$0
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $0 |
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $0 |
| 2023 | $0 |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED
- •Legislation to improve quality of care for cancer survivors, under development by Representative Debbie Wasserman Schultz
- •Development of cancer survivorship legislation to be introduced by Representative Wasserman Schultz.
- •Advice on the structure and financing of the Advanced Research Projects Agency for Health (ARPA-H).
- •Provide information as requested related to cancer survivorship legislation being developed by Representative Wasserman Schultz.
- •Cancer Survivorship legislation under development by Representative Wasserman Schultz Standards for distribution and use of monoclonal antibodies and antiviral treatments for the immune compromised
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.